Collaboration agreements - GlaxoSmithKline (Details) $ in Thousands |
1 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
|
Aug. 31, 2022
USD ($)
|
Dec. 31, 2023
USD ($)
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
Aug. 06, 2022
USD ($)
performanceObligation
|
|
| Collaboration agreements | |||||
| Collaboration revenue | $ 36,855 | $ 26,581 | $ 43 | ||
| Deferred revenue | 125,314 | 147,653 | $ 3,944 | ||
| GSK Agreement | |||||
| Collaboration agreements | |||||
| Upfront payment received | $ 100,000 | ||||
| Collaboration arrangement, potential option exercise receivable | 90,000 | ||||
| Revised transaction price | $ 100,000 | ||||
| Performance obligations identified | performanceObligation | 2 | ||||
| Collaboration revenue | 3,400 | 2,000 | |||
| Deferred revenue | $ 94,600 | $ 98,000 | |||
| GSK Agreement | Developmental, Commercial, And Regulatory | |||||
| Collaboration agreements | |||||
| Aggregate milestones | 1,300,000 | ||||
| GSK Agreement | Early Clinical Development | |||||
| Collaboration agreements | |||||
| Aggregate milestones | $ 30,000 | ||||
| X | ||||||||||
- Definition The amount the company is eligible to receive upon an option exercise as part of a collaboration arrangement. No definition available.
|
| X | ||||||||||
- Definition Maximum aggregate milestone the Company is entitled to receive under terms of the agreement. No definition available.
|
| X | ||||||||||
- Definition The number of material performance obligations identified under a collaboration arrangements related to designated targets No definition available.
|
| X | ||||||||||
- Definition The aggregate transaction price of a collaboration agreement as of the balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Cash received from collaborators during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|